Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRIT Capital Partners Regulatory News (RCP)

Share Price Information for RIT Capital Partners (RCP)

Share Price is delayed by 15 minutes
Get Live Data
2,320.00    5.00 (0.22%)
Bid:
2,295.00
Ask:
2,310.00
Spread: 15.00 (0.654%)
Market Cap: £3.14b
RCP Live PriceLast checked at - London Stock Exchange

Intraday RIT Capital Partners Share Chart

Net Asset Value(s)

17 Jun 2024 07:00

RNS Number : 5730S
RIT Capital Partners PLC
17 June 2024
 

RIT Capital Partners plc (LEI: P31Q1NLTW35JJGHA4667)

 

17 June 2024

 

31 May 2024 Net Asset Value

 

RIT Capital Partners plc announces that its unaudited diluted Net Asset Value ("NAV") as at 31 May 2024, calculated with debt at fair value, was 2,540p per £1 ordinary share (30 April 2024: 2,511p).

 

May 2024 Commentary

 

Global equities rebounded in May with US Federal Reserve continuing to signal interest rate cuts and economic data that supported the disinflation narrative, resulting in the S&P 500 rising by +5%. European shares also showed recovery, with STOXX 600 returning +3.5% reflecting the market's anticipation of a rate cut by the ECB. On the other hand, despite relatively robust economic data, China saw a -0.5% decline across the Shenzhen 300 as ongoing real estate debt pressures continue to weigh on investor sentiment. The US dollar gave back some of its year-to-date strength and fell -2% against sterling in the month. The price of gold continued to rise, reaching an all-time high of $2,450 in the same period.

 

Portfolio highlights

 

Our portfolio posted positive performance in May, with a total return of 1.1% despite a partial offsetting of returns caused by our exposure to the US dollar. This increase in value was driven by gains across all three of our strategic investment pillars.

 

·

An increase in the value of our Quoted Equities book was driven by healthy returns from our external managers and strong performance from our directly held small and mid-cap equities, an area where we currently see opportunity. With some expected offset on our portfolio hedges, the book saw a positive outcome overall. 

 

·

Private Investments were a solid contributor during the month, driven by gains from our private funds which saw an uplift in Q1 valuations. As of 31 May, 97% of our private funds were held at 31 March reported valuations and 2% were held at 31 December valuations. All private direct holdings are valued at 31 December, in line with our half-yearly valuation process for these holdings.

 

·

Uncorrelated Strategies also contributed positively to our total return for the month, driven largely by credit holdings performing strongly.

 

·

The Board continued its active buyback programme, generating a further accretive impact to the NAV per share. For the year to 31 May, the Company has repurchased approximately 1.5 million shares on behalf of shareholders.

 

 

 

For more information:

J. Rothschild Capital Management (Manager):

T: 020 7647 8565

E: investorrelations@ritcap.co.uk

 

Numis (Joint Broker):

David Benda

T: 020 7260 1000

 

JP Morgan Cazenove (Joint Broker):

William Simmonds

T: 020 3493 8000

 

Brunswick Group LLP (Media enquiries):

Nick Cosgrove, Sofie Brewis

T: 020 7404 5959

E: RIT@BrunswickGroup.com 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVEZLFFZQLZBBK
Date   Source Headline
12th Mar 20217:00 amRNSNet Asset Value(s)
11th Mar 20217:00 amRNSHolding(s) in Company
5th Mar 20219:38 amRNSDirector/PDMR Shareholding
2nd Mar 20217:00 amRNSAnnual Financial Report
26th Feb 20218:10 amRNSHolding(s) in Company
17th Feb 20217:00 amRNSHolding(s) in Company
15th Feb 20217:00 amRNSNet Asset Value(s)
4th Feb 20217:00 amRNSNet Asset Value(s)
23rd Dec 20207:00 amRNSTransaction in Own Shares
23rd Dec 20207:00 amRNSDirector/PDMR Shareholding
16th Dec 20207:00 amRNSTransaction in Own Shares
15th Dec 20207:00 amRNSTransaction in Own Shares
14th Dec 20207:00 amRNSNet Asset Value(s)
4th Dec 20205:36 pmRNSDirector/PDMR Shareholding
20th Nov 20204:04 pmRNSDirector/PDMR Shareholding
17th Nov 20205:27 pmRNSDirector/PDMR Shareholding
13th Nov 20207:00 amRNSNet Asset Value(s)
2nd Nov 20207:30 amRNSTransaction in Own Shares
30th Oct 20207:30 amRNSTransaction in Own Shares
15th Oct 20207:00 amRNSNet Asset Value(s)
15th Sep 20207:00 amRNSNet Asset Value(s)
17th Aug 20207:00 amRNSNet Asset Value(s)
4th Aug 20207:00 amRNSHalf-year Report
21st Jul 20207:00 amRNSNet Asset Value(s)
10th Jul 20205:25 pmRNSCommittee changes
18th Jun 20203:45 pmRNSDirector/PDMR Shareholding
15th Jun 20207:00 amRNSNet Asset Value(s)
26th May 20205:15 pmRNSResult of AGM
18th May 20207:00 amRNSNet Asset Value(s)
7th May 20206:02 pmRNSDirector/PDMR Shareholding
30th Apr 202011:12 amRNSDisclosure of Rights Attached To Ordinary Shares
21st Apr 202010:05 amRNSNotice of AGM
17th Apr 20207:00 amRNSNet Asset Value(s)
6th Apr 20205:41 pmRNSDirector/PDMR Shareholding
1st Apr 20204:06 pmRNSDirector/PDMR Shareholding
24th Mar 20205:16 pmRNSAnnual General Meeting 2020 postponement
16th Mar 20207:00 amRNSNet Asset Value(s)
11th Mar 20203:47 pmRNSDirector/PDMR Shareholding
3rd Mar 20207:00 amRNSAnnual Financial Report
17th Feb 20207:00 amRNSNet Asset Value(s)
5th Feb 20207:00 amRNSNet Asset Value(s)
7th Jan 20204:19 pmRNSQuarterly Disclosure: Listing Rule 15.6.8
17th Dec 20197:00 amRNSIssue of Equity
16th Dec 20197:00 amRNSNet Asset Value(s)
4th Dec 20195:02 pmRNSComposition of Board Committee
15th Nov 20197:00 amRNSNet Asset Value(s)
22nd Oct 20195:10 pmRNSHolding(s) in Company
14th Oct 20197:00 amRNSNet Asset Value(s)
3rd Oct 20193:17 pmRNSQuarterly Disclosure: Listing Rule 15.6.8
17th Sep 201912:18 pmRNSCorrection

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.